MI-2 (also known as MALT1 inhibitor) is a potent and irreversible MALT1 inhibitor with IC50 of 5.84 μM, and binds directly to MALT1, irreversibly suppresses protease function. MI-2 inhibits MALT1 functions in ABC-DLBCL cell lines with excellent cell penetration. MI-2 binds directly to MALT1 and irreversibly suppresses protease function. Decreases NF-κB activity induced by MALT1. MI-2 produces selective growth inhibition for MALT1-dependent cell lines with GI50 of 0.2, 0.5, 0.4, and 0.4 μM in HBL-1, TMD8, OCI-Ly3, and OCI-Ly10 cells, whereas the ABC-DLBCL MALT1-independent cell lines, U2932 and HLY-1, and the two GCB-DLBCL cell lines were resistant.
Physicochemical Properties
| Molecular Formula | C19H17CL3N4O3 | |
| Molecular Weight | 455.72 | |
| Exact Mass | 454.037 | |
| CAS # | 1047953-91-2 | |
| Related CAS # |
|
|
| PubChem CID | 45942672 | |
| Appearance | White to off-white solid powder | |
| Density | 1.44±0.1 g/cm3 | |
| LogP | 4.516 | |
| Hydrogen Bond Donor Count | 1 | |
| Hydrogen Bond Acceptor Count | 5 | |
| Rotatable Bond Count | 8 | |
| Heavy Atom Count | 29 | |
| Complexity | 525 | |
| Defined Atom Stereocenter Count | 0 | |
| InChi Key | TWJGQZBSEMDPQP-UHFFFAOYSA-N | |
| InChi Code | InChI=1S/C19H17Cl3N4O3/c1-28-8-9-29-19-24-18(12-2-7-15(21)16(22)10-12)26(25-19)14-5-3-13(4-6-14)23-17(27)11-20/h2-7,10H,8-9,11H2,1H3,(H,23,27) | |
| Chemical Name | 2-chloro-N-[4-[5-(3,4-dichlorophenyl)-3-(2-methoxyethoxy)-1,2,4-triazol-1-yl]phenyl]acetamide | |
| Synonyms |
|
|
| HS Tariff Code | 2934.99.9001 | |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
|
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| ln Vitro | MALT1-dependent DLBCL cell lines are selectively suppressed by the MALT1 inhibitor MI-2 (1-1000 nM; 48 hours); the GI50 in HBL-1, TMD8, OCI-Ly3, and OCI-Ly10 cells is 0.2, 0.5, 0.4, and 0.4 μM, respectively[1]. MALT1-mediated cleavage is reduced in a dose-dependent manner by the MALT1 inhibitor MI-2 (62-1000 nM; 24 hours)[1]. MALT1 blocker |
| ln Vivo | The growth of TMD8 and HBL-1 ABC-DLBCL xenografts is significantly suppressed by the MALT1 inhibitor MI-2 (25 mg/kg; ip; daily for 14 days)[1]. |
| Cell Assay |
Cell Proliferation Assay[1] Cell Types: HBL -1, TMD8, OCI-Ly3, OCI-Ly10 cells Tested Concentrations: 1, 10, 100, 1000 nM Incubation Duration: 48 hrs (hours) Experimental Results: The GI50 in HBL-1, TMD8, OCI-Ly3, and OCI-Ly10 cells was 0.2, 0.5, 0.4, and 0.4 µM, respectively. Western Blot Analysis[1] Cell Types: HBL-1 cells Tested Concentrations: 62, 125, 250, 500, 1000 nM Incubation Duration: 24 hrs (hours) Experimental Results: Inhibits MALT1 cleavage of CYLD in HBL -1 cells. |
| Animal Protocol |
Animal/Disease Models: Eightweeks old male SCID NOD ( bearing HBL-1 and TMD8 cells)[1] Doses: 25 mg/kg Route of Administration: intraperitoneal (ip)injection; daily for 14 days Experimental Results: Profoundly suppressed the growth of both the TMD8 and HBL-1 ABC-DLBCL xenografts versus vehicle. |
| References |
[1]. MALT1 small molecule inhibitors specifically suppress ABC-DLBCL in vitro and in vivo. Cancer Cell. 2012 Dec 11;22(6):812-24. |
| Additional Infomation | MALT1 Inhibitor is any agent that inhibits mucosa-associated lymphoid tissue lymphoma translocation protein 1 (MALT1). |
Solubility Data
| Solubility (In Vitro) |
|
|||
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.5 mg/mL (5.49 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.5 mg/mL (5.49 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly. Solubility in Formulation 3: 2% DMSO +30%PEG 300: 5 mg/mL  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.1943 mL | 10.9716 mL | 21.9433 mL | |
| 5 mM | 0.4389 mL | 2.1943 mL | 4.3887 mL | |
| 10 mM | 0.2194 mL | 1.0972 mL | 2.1943 mL |